The Symposium program will review the current patent law landscape and evaluate the impact on both the genetic diagnostics and biopharmaceutical sectors.  Sessions will review IP issues for both diagnostics generally and companion diagnostics.  Programming will also explore new collaborations and regulatory developments.  BIO aims to use this event to inform industry and government alike on how to move the science forward in the current climate.

Register »